MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1021/acsinfecdis.3c00611

Медицинская библиотека · ACS infectious diseases · 2024

Discovery of Salifungin as a Repurposed Antibiotic against Methicillin-Resistant Staphylococcus aureus with Limited Resistance Development.

Wang Chenchen, Ji Yueyue, Huo Xingyu, Li Xiaodan, Lu Wenjia, Zhang Zhaoran, Dong Wenqi, Wang Xiangru, Chen Huanchun, Tan Chen

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Exploring novel antimicrobial drugs and strategies has become essential to the fight MRSA-associated infections. Herein, we found that membrane-disrupted repurposed antibiotic salifungin had excellent bactericidal activity against MRSA, with limited development of drug resistance. Furthermore, adding salifungin effectively decreased the minimum inhibitory concentrations of clinical antibiotics against Staphylococcus aureus. Evaluations of the mechanism demonstrated that salifungin disrupted the level of H+ and K+ ions using hydrophilic and lipophilic groups to interact with bacterial membranes, causing the disruption of bacterial proton motive force followed by impacting on bacterial the function of the respiratory chain and adenosine 5'-triphosphate, thereby inhibiting phosphatidic acid biosynthesis. Moreover, salifungin also significantly inhibited the formation of bacterial biofilms and eliminated established bacterial biofilms by interfering with bacterial membrane potential and inhibiting biofilm-associated gene expression, which was even better than clinical antibiotics. Finally, salifungin exhibited efficacy comparable to or even better than that of vancomycin in the MRSA-infected animal models. In conclusion, these results indicate that salifungin can be a potential drug for treating MRSA-associated infections.

Для цитирования: Wang Chenchen, Ji Yueyue, Huo Xingyu, Li Xiaodan, Lu Wenjia, Zhang Zhaoran, Dong Wenqi, Wang Xiangru, Chen Huanchun, Tan Chen. Discovery of Salifungin as a Repurposed Antibiotic against Methicillin-Resistant Staphylococcus aureus with Limited Resistance Development.. ACS infectious diseases. 2024. DOI: 10.1021/acsinfecdis.3c00611.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.